Adjuvant chemotherapy in stage IB non-small cell lung cancer: if, when, how?

被引：0
作者：
M. Dediu
机构：
[1] Institute of Oncology Bucharest,Medical Oncology Department
来源：
memo - Magazine of European Medical Oncology | 2008年 / 1卷 / 2期
关键词：
Adjuvant chemotherapy; Stage IB; Risk factors; NSCLC;
D O I：
10.1007/s12254-008-0015-4
中图分类号：
学科分类号：
摘要：
Adjuvant chemotherapy is established as a standard of care for resectable non-small cell lung cancer. However, this indication remains controversial for the stage IB as the results of the randomized trials and meta-analysis are obscuring on this issue. Moreover, the updated international guidelines do not prescribe the regular use of this strategy in stage IB. The aim of this paper is to review the current evidences regarding the benefit of adjuvant CT in this setting, and to provide clinical hints, which can lend a helping hand to the clinicians and their patients to take the right decision in this particular scenario.
引用
收藏
页码：61 / 65
页数：4
相关论文
共 84 条
[1]  
Besse B(2007)Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 17 ii30-ii31
[2]  
Pignon JP(2006)Lung Adjuvant Cisplatin Evaluation (LACE): a pooled analysis of five randomized clinical trials including 4 584 patients J Clin Oncol 24 366s-129
[3]  
Tribodet H(2007)Surgery and adjuvant chemotherapy (CT) compared to surgery alone in non-small cell lung cancer (NSCLC): a meta-analysis using individual patient data (IPD) from randomized clinical trials (RCT) J Clin Oncol 25 397s-1461
[4]  
Scagliotti GV(1995)Incidence of local recurrence and second primary tumors in resected stage I lung cancer J Thorac Cardiovasc Surg 109 120-360
[5]  
Stewart LA(2003)Randomized study of adjuvant chemotherapy for completely resectd stage I, II or IIIA non-small cell lung cancer J Natl Cancer Inst 95 1453-2597
[6]  
Burdett S(2004)Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer N Engl J Med 350 351-727
[7]  
Tierney JF(2005)Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 352 2589-960
[8]  
Martini N(2006)Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol 7 719-1932
[9]  
Bains MS(2006)Adjuvant chemotherapy in Stage IB non-small cell lung cancer (NSCLC): update of cancer and leukemia group B (CALGB) Protocol 9633 J Clin Oncol 24 365s-1721
[10]  
Burt MS(2006)Postsurgical chemotherapy in stage IB nonsmall cell lung cancer: long-term survival in a randomized study Int J Cancer 119 955-80
123456789